23andMe
-
New 23andMe+ Report on Fibromyalgia
Sep 20
23andMe released a new report (powered by 23andMe Research) on Fibromyalgia for 23andMe+ members. Fibromyalgia is characterized by chronic pain and tenderness throughout the body. That pain can be intermittent and move to different parts of the body. Fibromyalgia symptoms can also include fatigue, problems sleeping, and difficulty concentratin...
-
23andMe Launches Rare Disease Study
Sep 8
Listening to those with a rare disease, a common refrain is that they often feel isolated, unheard, and alone. But, they’re not alone, 23andMe says. Much to Learn While each rare disease is by definition uncommon - affecting fewer than 200,000 people - there are more than 7,000 known rare diseases. There are more than 300 million peopl...
-
23andMe Announces A New Genetic Study On Pneumonia
Aug 25
23andMe announced that a new genetic study identified five regions in the human genome associated with susceptibility to pneumonia, a leading cause of death worldwide. Published in the journal Nature Communications, the study also found a surprising link between the risk of pneumonia and psychiatric conditions, such as schizophrenia, bipola...
-
Study On Side Effects of Parkinson’s Medication
Aug 11
23andMe posted information on a new genetic study that may help those looking for ways to avert some of the troubling side effects of a common medication used to treat Parkinson’s disease. Parkinson’s is sometimes treated with medication that increases dopamine activity in the brain. In some patients, that triggers impulsivity, such as ...
-
New 23andMe Report on Rosacea
Jul 13
23andMe released a new report Powered by 23andMe Research on Rosacea for 23andMe+ members. Rosacea is a chronic skin condition that typically affects the central parts of the face. It is commonly characterized by flushing, redness, and visible blood vessels, but symptoms can vary; some individuals experience irritation or inflammation of th...
-
23andMe Updated Report for People with Asian Ancestry
Jun 21
23andMe updated its report on an inherited condition characterized by mild to profound hearing loss. The update to 23andMe’s Nonsyndomic Hearing Loss and Deafness, DFNB1 (GJB1-Related) Carrier Status Report adds six variants that improve the coverage of the test for people with East Asian, Southeast Asian, and South Asian ancestry. “We ...
-
23andMe Has A Study About Long COVID
Jun 1
In what is among the largest studies of long COVID to date, researchers at 23andMe confirm that it disproportionately impacts women, and being diagnosed with depression or anxiety is associated with more than a two-fold increase in risk for the condition. The study also found that about half of those with persistent symptoms are experiencing ...
-
23andMe Acquired Lemonaid Health
May 10
23andMe announced another step toward unlocking the power of genetic health information. 23andMe acquired Lemonaid Health, a telemedicine company, last fall. Instead of being treated for an illness, most of us would prefer to avoid getting sick in the first place. But in large measure, our health care system isn’t geared for that. It’...
-
23andMe New Study on Depression and Bipolar Disorder
Apr 12
A 23andMe study published in April of 2022 provides insight into the cause and overlapping genetics of two mental health disorders - depression and bipolar disorder. The National institutes of Health estimates that more than 16 million Americans are affected by depression each year, while nearly 6 million Americans have bipolar disorder. Ge...
-
California Expands Consumer Protections for Genetic Testing
Oct 21
23andMe knows you care about privacy, and they have been working hard to deliver other promises of transparency and choice, even beyond your experience at 23andMe. 23andMe is excited to share that California recently enacted a new law to protect consumers’ genetic data privacy. 23andMe has worked hard with the Coalition for Genetic Data P...